Instantly diagnose and manage respiratory disease using only a smartphone.

See how ResApp improves telehealth

Instantly diagnose and manage respiratory disease using only a smartphone.

See how ResApp improves telehealth

ResApp develops digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease.

We will provide telehealth companies with point of care diagnostic solutions that can be easily integrated into their platforms.

We are working on apps to provide instant clinical quality diagnostic tests and management tools directly to consumers and healthcare providers.

A world-leading technology platform

Over the last five years the research team, led by Associate Professor Udantha Abeyratne at The University of Queensland, has pioneered algorithms that accurately characterise the state of patients’ respiratory tracts. The team has created a powerful platform for respiratory disease diagnosis and management which only requires the sound of the patient’s cough or breathing and does not require physical contact. With the high quality microphones in today’s smartphones the platform can be delivered without the need for additional hardware.

Recent Press

Preliminary data: ResApp’s new platform detects sleep apnea with 86% sensitivity

13 April 2018

Brisbane, Australia-based ResApp Health, a digital health company that specializes in diagnosing respiratory diseases, is now conducting clinical proof-of-concept studies for its latest technology that uses a smartphone to detect sleep apnea by sound. Read the article

ResApp Logo White

ResApp Health Limited
ABN 51 094 468 318
Headquarters: Level 8, 127 Creek St, Brisbane, QLD 4000
Registered Office: Level 24, 44 St Georges Tce, Perth, WA 6000

© 2018 ResApp Health Limited. All Rights Reserved.

CONTACT US
+61 8 6211 5099
+61 8 9218 8875
General Information
Clinical Studies
Investor Relations

    

LEGAL
Terms of Use
Privacy Policy

ResApp Health®, the ResApp Health logo and ResAppDx® are registered trademarks of ResApp Health Limited in the United States.

In the United States, ResAppDx is an investigational device and is not available for sale.